Vogue Commercial Co. Ltd Corporate News-Glenmark Pharmaceuticals Ltd | BFSL
Reach out to us on 0120-4918900 Or
Get a call back Click here

Markets

Share Price

CORPORATE NEWS

You can view News of the company.
Glenmark Pharmaceuticals Ltd.
GO
ISIN No INE935A01035 Market Cap. ( in Cr. ) 54622.79 P/BV 6.47 Book Value ( ) 299.28
BSE Code 532296 52 Week High/Low ( ) 2285/1276 FV/ML 1/1 P/E(X) 52.17
NSE Code GLENMARKEQ Book Closure 03/10/2025 EPS ( ) 37.10 Div Yield (%) 0.13
Date and TimeHeadlines
27-Sep-2025 7:50AM Glenmark Pharma has declared 250% Interim dividend for the financial year March 2026
26-Sep-2025 7:10PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
26-Sep-2025 7:10PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
26-Sep-2025 7:10PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
26-Sep-2025 7:10PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
26-Sep-2025 7:10PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
26-Sep-2025 7:03PM Glenmark Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM
26-Sep-2025 7:02PM Glenmark Pharma - Shareholders meeting
26-Sep-2025 11:09AM Glenmark Pharma - Record Date
26-Sep-2025 11:04AM Glenmark Pharma - Corporate Action-Board approves Dividend